ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "genetics"

  • Abstract Number: 0904 • ACR Convergence 2024

    Defining the Function of Disease Variants with CRISPR Editing and Multimodal Single Cell Sequencing

    Yuriy Baglaenko1, MIchelle Curtis2, Majd Al Suqri3, Ryan Agnew3, Aparna Nathan4, Hafsa Mire4, Annelise Yoo Mah-Som3, David Liu5, Gregory Newby6 and Soumya Raychaudhuri3, 1Cincinnati Children's Hospital, Cincinnati, OH, 2Broad Institute, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4Harvard Medical School, Boston, MA, 5Broad Institute, Cambridge, MA, 6Johns Hopkins, Baltimore, MD

    Background/Purpose: Genetic studies have identified thousands of individual disease-associated non-coding alleles, but identification of the causal alleles and their functions remain critical bottlenecks. Even though…
  • Abstract Number: 1424 • ACR Convergence 2024

    Associations of Human Leukocyte Antigens (HLA) Class II with Interstitial Lung Disease (ILD) in Patients with Systemic Autoimmune Rheumatic Diseases (SARDs). A Prospective Study in Sequential Patients with SARD-ILD

    Panagiotis Panagopoulos1, Loukas chatzis2, Vasiliki Kitsiou3, Katerina Tarassi3, Eirini Chatzinikita4, Katerina Malagari5, Theodoros Vassilakopoulos4, Alexandra Tsirogianni3, Andreas Goules6 and Athanasios Tzioufas7, 1Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 2Pathophysiology Department, Athens School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, Cholargos Athens, Greece, 3Immunology and Histocompatibility Department, Evangelismos General Hospital, Athens, Greece, 4Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 52nd Department of Radiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece, 6GENERAL HOSPITAL LAIKO ATHENS, Athens, Greece, 7LAIKO HOSPITAL, Athens, Greece

    Background/Purpose: Genetic studies in various systemic autoimmune rheumatic diseases (SARDs) support that human leukocyte antigen (HLA) class II alleles are associated with specific autoimmune disorders…
  • Abstract Number: 2202 • ACR Convergence 2024

    Evolving Phenotypic and Genotypic Spectrum of Human ISG15 and USP18 Deficiencies

    Alhanouf Alsaleem1, Wafaa Abdulghaffar2, Lujain Akbar3, Meshal Alhassan4, Fatimah Alkhars5 and Sulaiman Al-Mayouf6, 1KFSH&RC, Riyadh, Saudi Arabia, 2KFSHRC, RIYADH, RIYADH, 3RIYADH, RIYADH, Saudi Arabia, 4Imam Abdulrahman Bin Faisal University, DAMMAM, 5Maternity and children hospital, ALHASSA, 6KFSHRRC, Riyadh, Saudi Arabia

    Background/Purpose: Loss of negative regulator in ISG15 and USP18 results in recently described immunodysregulatory disorders with diversity of clinical characteristics related to enhanced IFN-a/b immunity.…
  • Abstract Number: 0907 • ACR Convergence 2024

    Association of Rare and Common Genetic Variants in MOCOS with Inadequate Response to Allopurinol

    Niamh Fanning1, Murray Cadzow2, Ruth Topless3, Chris Frampton4, Nicola Dalbeth5, Tony Merriman6 and Lisa Stamp4, 1University of Otago, Christchurch, New Zealand, 2University of Otago, Dunedin 9054, New Zealand, 3University of Otago, Dunedin, New Zealand, 4University of Otago, Christchurch, Christchurch, New Zealand, 5University of Auckland, Auckland, New Zealand, 6University of Alabama at Birmingham, Homewood, AL

    Background/Purpose: The minor allele of the common rs2231142 (Q141K) ABCG2 variant predicts inadequate response to allopurinol urate lowering therapy (ULT). We hypothesize that additional variants in genes…
  • Abstract Number: 1761 • ACR Convergence 2024

    Juvenile Idiopathic Arthritis Genetic Risk Haplotypes: Relevance to Children of African Ancestry

    Sabrina George1, Hannah C Ainsworth2, Kaiyu Jiang3, Gilad Barshad4, Adam He4, Edward Rice4, Carl D Langerfeld2, Charles G Danko4 and James N Jarvis3, 1University at Buffalo Jacobs School of Medicine, Buffalo, NY, 2Wake Forest University, Winston-Salem, NC, 3University of Washington School of Medicine, Seattle, WA, 4Cornell University Baker School of Veterinary Medicine, Ithaca, NY

    Background/Purpose: - Numerous juvenile idiopathic arthritis (JIA) risk loci have been identified, overwhelmingly from cohorts of children of European ancestry (EA). The extent to which…
  • Abstract Number: 2282 • ACR Convergence 2024

    Defining a Personalized Treatment Approach to Rheumatoid Arthritis: Using Genetic Markers of TNFi Response

    M. Elaine Husni, Judy Zhang, Jean Lin, Yuxuan Jin and Unnikrishnan Chandrasekharan, Cleveland Clinic, Cleveland, OH

    Background/Purpose: The development of a personalized medicine approach to identify responders and non-responders to tumor necrosis factor alpha (TNFα) inhibiting agents for rheumatoid arthritis (RA)…
  • Abstract Number: 0908 • ACR Convergence 2024

    Clinical Characteristics of Patients with High SLE-specific and High Multitrait Polygenic Risk – an Investigation of SLE Risk Loci

    Nina Oparina1, Sarah Reid2, Ahmed Sayadi3, Maija-Leena Eloranta4, Martina Frodlund5, Karoline Lerang6, Andreas Jönsen7, Solbritt Rantapaa-Dahlqvist8, Anders Bengtsson7, Anna Rudin9, Øyvind Molberg10, Christopher Sjowall11, Lars Rönnblom4 and Dag Leonard4, 1UU, Uppsala, Sweden, 2Uppsala University, Medical Sciences, Uppsala, Sweden, 3Uppsala, Uppsala, Sweden, 4Uppsala University, Uppsala, Sweden, 5Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, Linköping, Sweden, 6Oslo University, Oslo, Norway, 7Lund University, Lund, Sweden, 8Umeå University, Umeå, Sweden, 9Institute of Medicine, University of Gothenburg, Gothenburg, Sweden, 10Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, 11Linköping University, Linköping, Sweden

    Background/Purpose: Heritability of SLE is high and more than 200 genetically associated SLE risk loci were identified. Part of them  are specific and associate with…
  • Abstract Number: 1766 • ACR Convergence 2024

    STAT2-Associated Type I Interferonopathy: A Masquerade of Infectious Susceptibility

    Conor Gruber1, Angelica Lee2, Sofija Buta2, Marta Martin Fernandez2, Veronique Houdouin3, Jean-Laurent Casanova4, Alice Hadchouel5, Jacinta Bustamante5 and Dusan Bogunovic2, 1Mount Sinai Hospital, New York, NY, 2Columbia University, New York, NY, 3Robert Debré Hospital, Paris, France, 4Rockefeller University, New York, NY, 5Hôpital Necker-Enfants Malades, Paris, France

    Background/Purpose: Type I IFN (IFN-I) signaling is a potent inflammatory pathway fundamental to antiviral immunity. In humans, loss of IFN-I activity underlies severe viral disease,…
  • Abstract Number: 2373 • ACR Convergence 2024

    The Construction and Validation of Sub-phenotype-specific Genetic Risk Scores in Systemic Lupus Erythematosus: A Novel Approach Using Large-scale Biobank Data

    Sarah Reid1, Johanna Sandling2, Pascal Pucholt3, Ahmed Sayadi4, Martina Frodlund5, Karoline Lerang6, Andreas Jönsen7, Christopher Sjowall8, Iva Gunnarsson9, Ann-Christine Syvänen2, Anders Bengtsson7, Øyvind Molberg10, Elisabet Svenungsson11, Anna Rudin12, Solbritt Rantapaa-Dahlqvist13, Lars Rönnblom2 and Dag Leonard2, 1Uppsala University, Medical Sciences, Uppsala, Sweden, 2Uppsala University, Uppsala, Sweden, 3Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala university, Uppsala, Sweden, 4Uppsala, Uppsala, Sweden, 5Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, Linköping, Sweden, 6Oslo University Hospital, Oslo, Norway, 7Lund University, Lund, Sweden, 8Linköping University, Linköping, Sweden, 9Karolinska Institute, Stockholm, Sweden, 10Oslo University Hospital, Department of Rheumatology, Oslo, Nepal, 11Karolinska Institutet, Stockholm, Sweden, 12Institute of Medicine, University of Gothenburg, Gothenburg, Sweden, 13Umeå University, Umeå, Sweden

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease with a heterogeneous clinical picture. This study aimed to link genetic SLE predisposition with relevant clinical…
  • Abstract Number: 0055 • ACR Convergence 2024

    Activating STAT3 Mutations in CD8+ T Cells Correlate to Serological Positivity in Rheumatoid Arthritis

    Katharine moosic1, Thomas Olson2, Mark Freijat3, samara khalique4, Cait Hamele1, Bryna Shemo1, Jesse Boodoo5, William Baker6, Gitanjali Khurana7, Matthew Schmachtenberg8, Tristin Duffy8, Aakrosh Ratan1, Erika Darrah9, Felipe Andrade10, Marieke Jones8, Kristine Olson2, David Feith1, Thomas Loughran1 and Donald Kimpel1, 1University of Virginia, Charlottesville, VA, 2Virginia Commonwealth University, Richmond, VA, 3Flow Rheumatology, Scottsdale, AZ, 4Carilion Clinic/ VirginiaTech, Salem, VA, 5Sarasota Arthritis Center, Sarasota, FL, 6Atrium Health, Charlotte, NC, 7University of Virginia, CROZET, VA, 8University of Virginia, Charlottesville, 9Johns Hopkins University, Baltimore, MD, 10The Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose: Large granular lymphocyte (LGL) leukemia is a rare hematologic malignancy characterized by clonal expansion of cytotoxic T-cells and frequent somatic activating STAT3 mutations. A…
  • Abstract Number: 0910 • ACR Convergence 2024

    Reduced Adenosine-Mediated Regulatory Activity Exacerbated by an NT5E Loss of Function Mutation Is Linked to Tissue Inflammation and Hypertension in Systemic Lupus Erythematosus

    Katherine Owen1, Isaac Peabody2, Mikhail Olferiev3, Tyson Dawson2, Prathyusha Bachali4, Peter Kasson5, Amrie Grammer6, Mary Crow3 and Peter Lipsky2, 1RILITE, Charlottesville, VA, 2Ampel Biosolutions, Charlottesville, VA, 3Hospital for Special Surgery, New York, NY, 4AMPEL BioSolutions, Redmond, WA, 5University of Virginia, Charlottesville, VA, 6AMPEL LLC, Charlottesville, VA

    Background/Purpose: Adenosine is a purine nucleoside generated by the enzymatic activity of CD73/NT5E, that functions as an endogenous regulator of the immune system critical for…
  • Abstract Number: 1773 • ACR Convergence 2024

    Divergent Genetic Architecture in Boys and Girls with NEMO-deleted Exon 5 Autoinflammatory Syndrome (NEMO-NDAS) Implies Role for Wildtype Effector Cells

    Adriana Almeida de Jesus1, Kip Friend2, Bin Lin3, Eric Karlins4, Colton McNinch4, Sara Alehashemi5, Keith Kauffman6, FARZANA BHUYAN3, Taylor Newbolt6, Andrea Bohrer7, Andre Rastegar3, Sophia Park3, Dana Kahle3, Jacob Mitchell3, Amanda Chen3, Sofia Torreggiani8, Kader Cetin Gedik9, Katsiaryna Uss2, Amer Khojah10, Eveline Wu11, Christiaan Scott12, Timothy Ronan Leahy13, Emma MacDermott14, Orla Killeen15, Thaschawee Arkachaisri16, Brian Nolan17, Zoran Gucev18, Kathryn Cook19, Vafa Mammadova20, Gulnara Nasrullayeva20, Mariana Correia Marques21, Abigail Bosk22, Seza Ozen23, Scott Canna24, Maude Tusseau25, Emilie Chopin26, Guilaine Boursier27, Veronique Hentgen28, Ines Elhani29, Mario Sestan30, Marija Jelusic31, Danielle Fink32, Douglas Kuhns32, Clifton Dalgard33, Alexandre Belot34, Timothy Moran11, Katherine Meyer-Barber7, Andrew Oler4, Daniel Barber6 and Raphaela Goldbach-Mansky35, 1NIAID, NIH, Silver Spring, MD, 2Translational Autoinflammatory Diseases section (TADS), LCIM, NIAID, NIH, Bethesda, MD, 3TADS, NIAID, NIH, Bethesda, MD, 4BCBB, NIAID, NIH, Bethesda, MD, 5NIH/NIAID/TADS, Potomac, MD, 6T Lymphocyte Biology Section, LPD, NIAID, NIH, Bethesda, MD, 7Inflammation and Innate Immunity Unit, LCIM, NIAID, NIH, Bethesda, MD, 8University Of Maryland Baltimore, Baltimore, MD, 9Translational Autoinflammatory Diseases section (TADS), LCIM, NIAID, NIH, Pittsburgh, PA, 10Umm Al-Qura University, Makkah, Saudi Arabia, 11University of North Carolina School of Medicine, Chapel Hill, NC, 12University of Cape Town, Cape Town, South Africa, 13Children’s Health Ireland (CHI) at Crumlin, Dublin, Ireland, 14CHI Crumlin, Dublin, Dublin, Ireland, 15Children's Health Ireland, Dublin, Ireland, 16KK Women's and Children's Hospital, SingHealth, Singapore, Singapore, 17Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, 18University Children's Hospital, Skopje, Macedonia, 19Akron Children's Hospital, Akron, OH, 20Azerbaijan Medical University, Baku, Azerbaijan, 21National Institutes of Health, Bethesda, MD, 22Children's National Hospital, Bethesda, DC, 23Department of Pediatrics, Hacettepe University, Ankara, Turkey, 24Children's Hospital of Philadelphia, Philadelphia, PA, 25RAISE, Hospices Civils de Lyon, Lyon, France, 26Hospices Civils de Lyon, Lyon, France, 27University of Montpellier, Montpellier, 28Laboratoire de Génétique des Maladies Rares et Autoinflammatoires, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CEREMAIA, CHU de Montpellier, Univ Montpellier, Montpellier, France, Le Chesnay, France, 29Department of Internal Medicine, Caen University Hospital, Caen, France, Caen, France, 30University of Zagreb School of Medicine University Hospital Centre Zagreb, Zagreb, Croatia, 31University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Zagreb, Croatia, 32Collaborative Clinical Research Branch, NIAID, NIH, Bethesda, MD, Bethesda, MD, 33The American Genome Center, Department of Anatomy, Physiology & Genetics, Uniformed Services University, Bethesda, MD, 34Hospices Civils de Lyon, Collonges au mont d'or, France, 35Translational Autoinflammatory Diseases section (TADS), LCIM, NIAID, NIH, Potomac, MD

    Background/Purpose: Splice-site variants in X-linked IKBKG cause NEMO-deleted exon5 autoinflammatory syndrome (NEMO-NDAS); a pseudogene (IKBKGP1) complicates genetic diagnosis. NEMO-NDAS is four times more common in…
  • Abstract Number: 2387 • ACR Convergence 2024

    Biomarkers of Lupus Nephritis Are Less Predictive in APOL1 High Risk Genotype Lupus

    Madeline Alizadeh1, Vishnuprabu Pandian1, Christele Felix2, Andrra Nimoni2, Jasmin Divers3, Timothy Niewold2 and Ashira Blazer1, 1University of Maryland Baltimore, Baltimore, MD, 2Hospital for Special Surgery, New York, NY, 3NYU School of Medicine, New York, NY

    Background/Purpose: Compared to Apolipoprotein L1 (APOL1) low risk genotype (LRG) patients, APOL1 (HRG) has been shown to increase the risk of chronic kidney disease in…
  • Abstract Number: 0114 • ACR Convergence 2024

    Rare Germline Variants in Complement Regulatory Genes in Antiphospholipid Antibody Positive Patients: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

    Cécile Yelnik1, shruti chaturvedi2, Julien Labreuche3, Xiang-Zuo Pan2, H Michael Belmont4, Nina Kello5, Paul Fortin6, David Branch7, Yu Zuo8, Rohan Willis9, Robert Brodsky2, Jane Salmon10, Maria Laura Bertolaccini11, Hannah Cohen12, Michelle Petri13 and Doruk Erkan10, and on behalf of APS ACTION, 1lille university, Lille, France, 2John Hopkins University, Baltimore, MD, 3Lille University Hospital, Lille, France, 4NYU Langone Health, New York, NY, 5Northwell Health, Brooklyn, NY, 6Centre ARThrite - CHU de Québec - Université Laval, Quebec, QC, Canada, 7University of Utah and Intermountain Healthcare, Salt Lake City, UT, 8University of Michigan, Ann Arbor, MI, 9University of Texas Medical Branch, Galveston, TX, 10Hospital for Special Surgery, New York, NY, 11King's College London, London, United Kingdom, 12University College London Hospitals NHS Foundation Trust, London, United Kingdom, 13Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose: We previously reported that markers of complement activation, specifically elevated C4d levels and positive modified HAM (mHAM) test, are associated with a higher risk…
  • Abstract Number: 0912 • ACR Convergence 2024

    Next-Generation Sequencing in Molecular Genetics of Adult-Onset Still’s Disease: Data from 23 Patients and Literature Review

    Belén Atienza-Mateo1, Diana Prieto-Peña1, Eztizen Labrador-Sánchez2, Natalia Palmou Fontana1, Rafael Benito Melero-Gonzalez3, Fred Anton Pages4, Carmen Alvarez Reguera5, Nerea Paz-Gandiaga6 and Ricardo Blanco-Alonso7, 1Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Cantabria, Spain, 2Hospital General de La Rioja, Logroño, Spain, 3CHU Ourense, O Carballino, Spain, 4Complejo Asistencial De Segovia, Segovia, Spain, 5Hospital Universitario Marqués de Valdecilla, Santander, Spain, 6Department of Genetics, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 7Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: Molecular genetic techniques are becoming increasingly essential tools for the diagnosis of monogenic systemic autoinflammatory diseases (SAIDs). However, their role in the diagnosis of…
  • 1
  • 2
  • 3
  • …
  • 26
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology